Commercial

CGM-connected app feature for Type 2 diabetes patients, unveiled by Abbott and WeightWatchers

One year after allying with the shared objective of enhancing health management for individuals diagnosed with Type 2 diabetes, Abbott and WeightWatchers...

Fresh Tracks Set to Dissolve with no Buyer in the Pipeline

After months of looking into various other possibilities, Fresh Tracks Therapeutics has decided to dissolve its operations, as the board of directors...

Sanofi divests 11 CNS medications to Pharmanovia in a strategic slimming-down move

In a strategic maneuver aimed at streamlining its product portfolio, pharmaceutical juggernaut Sanofi has initiated the sale of 11 central nervous system...

Kroger Health Joins Hands With Performance Kitchen to Provide Medically Tailored Food

Kroger Health, a division of the Kroger Company, has partnered with Performance Kitchen to provide patients suffering from chronic diseases with meals...

BioNTech receives $90 million from CEPI partnership

BioNTech is in the midst of conducting clinical trials for its mRNA-based mpox vaccine, propelled by a substantial $90 million grant from...

BMS Terminates Two Mid-Stage and Four Early-Stage Clinical Initiatives

During an R&D Day presentation, Bristol Myers Squibb (BMS) made significant alterations to its development pipeline. The company announced that it will...

Novo Nordisk’s Wegovy Launch in UK Amid Competition

Novo Nordisk has initiated the rollout of its Wegovy weight loss injection in the United Kingdom, marking a significant step in expanding...

Moderna Forms Multi-Billion Dollar Strategic Partnership with Immatics

Moderna has entered into a significant research partnership with Immatics, focusing on cancer vaccines and cell therapies. This collaboration has the potential...

Latest news

CGM-connected app feature for Type 2 diabetes patients, unveiled by Abbott and WeightWatchers

One year after allying with the shared objective of enhancing health management for individuals diagnosed with Type...

With the trial’s success, AbbVie prepares Botox for a different aesthetic use

Recently, AbbVie disclosed positive outcomes from a second phase 3 trial of Botox, aimed at managing moderate...

Fresh Tracks Set to Dissolve with no Buyer in the Pipeline

After months of looking into various other possibilities, Fresh Tracks Therapeutics has decided to dissolve its operations,...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

You might also likeRELATED
Recommended to you

Azurity acquires Arbor Pharmaceuticals to form an integrated entity

Azurity Pharmaceuticals Inc. has signed an agreement...

CytoReason and Pfizer extend their alliance for AI delivery in drug discovery

Both companies have lengthened their collaboration to...

Life Sciences Voice Top Five Newsletter

This week we take a look at...